4-Ethylmethcathinone
4-Ethylmethcathinone (4-EMC) is a psychoactive drug and research chemical belonging to the cathinone class, which is a group of compounds derived from the khat plant. It is structurally related to methcathinone, differing only by the addition of an ethyl group at the β position. This modification imparts unique pharmacological properties, distinguishing 4-EMC from its more commonly known relative, mephedrone (4-MMC).
Chemistry[edit | edit source]
4-Ethylmethcathinone is a synthetic cathinone and is part of the larger family of amphetamine-like compounds. It possesses a core phenethylamine structure with an alkyl group attached to the alpha carbon and an oxygen group attached to the beta carbon. The ethyl group at the β position is what differentiates 4-EMC from other synthetic cathinones.
Pharmacology[edit | edit source]
The pharmacological action of 4-EMC is primarily due to its ability to inhibit the reuptake of neurotransmitters such as dopamine, serotonin, and norepinephrine, leading to an increase in their concentrations in the central nervous system. This mechanism of action is similar to other stimulants and entactogens, which can produce feelings of euphoria, increased energy, and sociability.
Effects[edit | edit source]
The effects of 4-EMC can vary significantly among users, but common reported effects include:
- Euphoria
- Increased energy and alertness
- Enhanced sociability
- Altered perception of time
- Decreased appetite
However, like all psychoactive substances, 4-EMC also poses risks of adverse effects, which can include:
- Anxiety and paranoia
- Insomnia
- Nausea and vomiting
- Increased heart rate and blood pressure
- Potential for dependence and abuse
Legal Status[edit | edit source]
The legal status of 4-EMC varies by country, with some jurisdictions having specific legislation controlling its sale, distribution, and use. It has been classified as a controlled substance in several countries due to concerns about its potential for abuse and harm.
Safety[edit | edit source]
Due to its status as a research chemical, the safety profile of 4-EMC is not well-established. Users are advised to exercise caution, as the long-term health effects are unknown. Harm reduction practices, such as starting with lower doses and testing substances for purity, are recommended.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD